The Effects of a Fish Oil Preparation (EPAGIS) on Serum Lipids, Apoproteins, Circulating Platelet Aggregates and Hemorheologic Parameters in Hyperlipidemic Subjects

  • P. Green
  • J. Fuchs
  • P. Budowski
  • Y. Lurie
  • I. Beigel
  • J. Agmon
  • L. Leibovici
  • R. Mamet
  • N. Schoenfeld

Abstract

Fish oil as a means of preventing cardiovascular disease has recently attracted much attention (1). Many studies on the effects of fish oil ingestion on various cardiovascular risk factors were published, but only a few were well controlled and double-blind (2). The aims of our study were to examine the effects of a moderate intake of fish oil on several cardiovascular risk factors including serum lipids, apoproteins, some platelet functions and hemorheologic parameters in hyperlipidemic subjects, in a randomized, controlled, double-blind, cross-over fashion.

Keywords

Plasma Viscosity Erythrocyte Deformability Erythrocyte Fatty Acid Hyperlipidemic Subject Hemorheologic Parameter 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Leaf A. and P.C.Weber,(1988) Cardiovascular effects of n-3 fatty acids. N.Eng.J.Med. 318, 549Google Scholar
  2. 2.
    Herold P.M. and J.E.Kinsella (1986) Fish oil consumption and decreased risk of cardiovascular disease: a comparison of findings from animal and human trials. Am.J.Clin.Nutr. 43, 566PubMedGoogle Scholar
  3. 3.
    Slutzky et al. (1987) Quantitative determination of apolipoproteins A-1 and B with a rapid immunoturbidimetric assay. Clin.Chem. 33, 897Google Scholar
  4. 4.
    Fuchs J., (.Weinberger, Z.Rotenberg et al. (1987) Circulating aggregated platelets in coronary artery disease. Am.J.Cardiol. 60, 534PubMedCrossRefGoogle Scholar
  5. 5.
    Weinberger I., J.Fuchs, Z.Rotenberg et aí. (1986) Circulating platelet aggregate size in ischemic heart disease. Angiology 37, 676CrossRefGoogle Scholar
  6. 6.
    Reid H.J., A.J.Barner, P.J.Lock et al. (1976) A simple method for measuring erythrocyte deformability. J.Clin.Pathol. 29, 855PubMedCrossRefGoogle Scholar
  7. 7.
    Connor W.E., Hypolipidemic effects of dietary omega-3 fatty acids in normal and hyperlipidemic humans: effectiveness and mechanisms. In: Health effects of polyunsaturated fatty acids in seafoods, A.P.Simopoulos, R.R.Kifer and R.E.Martin eds.,Academic Press,Inc., 1986Google Scholar
  8. 8.
    Central Bureau of Statistics, Jerusalem: Food Balance Sheets, 1985/86Google Scholar
  9. 9.
    Blondheim S.H., T.Horne, R.Davidovich et al. (1976) Unsaturated fatty acids in adipose tissue of Israeli Jews. Isr.J.Med.Sci. 12, 658PubMedGoogle Scholar
  10. 10.
    Sanders T.A.B., D.R.Sullivan, J.Reeve et al. (1985) Triglyceride lowering effect of marine polyunsaturates in patients with hyper-triglyceridemia. Arteriosclerosis 5, 459PubMedCrossRefGoogle Scholar
  11. 11.
    Simons L.A., J.B.Hickie, S.Balasubramaniam (1985) On the effects of dietary n-3 fatty acids ( MaxEPA) on plasma lipids and lipoproteins in patients with hyperlipidemia. Atherosclerosis 54, 75Google Scholar
  12. 12.
    Boberg M., B.Vessby, I.Selinus (1986) Effects of dietary supplementation with n-6 and n-3 long chain polyunsaturated fatty acids on serum lipoproteins and platelet function in hypertriglyceridemic patients. Acta Med.Scand. 220, 153PubMedCrossRefGoogle Scholar
  13. 13.
    Schectman G., S.Kaul, A.H.Kissebah (1987) Effect of fish oil concentrate on HDL-cholesterol and apo A-1 levels in hypertriglyceridemic subjects. Arteriosclerosis 7, 508a (abstract)Google Scholar
  14. 14.
    Sullivan D.R., T.A.B.Sanders, I.M.Trayner et al. (1986) Paradoxical elevation of LDL apoprotein B levels in hypertriglyceridemic patients and normal subjects ingesting fish oil. Atherosclerosis 61, 129PubMedCrossRefGoogle Scholar
  15. 15.
    Harris W.S., C.A.Dujovne, M.L.Zucker et al. (1987) Fish oil supplements raise low density lipoprotein cholesterol levels in hypertriglyceridemic patients. Arteriosclerosis 7, 509a (abstract)Google Scholar
  16. 16.
    Phillipson B.E., D.W.Rothrock, W.E.Connor et al. (1985) Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N.Eng.J.Med. 312, 1210CrossRefGoogle Scholar
  17. 17.
    Tamura Y., A.Hirai, T.Terano et al. (1986) Clinical and epidemiological studies of eicosapentaenoic acid ( EPA) in Japan. Prog.Lipid Res. 25, 461.Google Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • P. Green
    • 1
    • 2
    • 5
  • J. Fuchs
    • 2
    • 3
  • P. Budowski
    • 4
  • Y. Lurie
    • 1
    • 2
    • 5
  • I. Beigel
    • 1
    • 2
    • 5
  • J. Agmon
    • 2
    • 3
  • L. Leibovici
    • 1
  • R. Mamet
    • 6
  • N. Schoenfeld
    • 6
  1. 1.Dept.Internal Medicine BBeilinson Med.Ctr.Petah TiqvaIsrael
  2. 2.Tel Aviv Univ. Sackler Sch.Med.Tel AvivIsrael
  3. 3.Dept.Internal Med. A and Israel and Ione Massada Ctr.Heart Dis.Beilinson Med.Ctr.Petah TiqvaIsrael
  4. 4.Fac.Agric.The Hebrew Univ. of JerusalemRehovotIsrael
  5. 5.The Lipid Unit and “Salah” Lab.Lipid Res.Beilinson Med.Ctr.Petah TiqvaIsrael
  6. 6.The Lab.Biochem.Pharmacol.Beilinson Med.Ctr.Petah TiqvaIsrael

Personalised recommendations